• 1
    Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut 1999; 45 (Suppl. 2): 616.
  • 2
    Porter AJ, Wattchow DA, Brookes SJ, Schemann M, Costa M. Choline acetyltransferase immunoreactivity in the human small and large intestine. Gastroenterology 1996; 111: 4018.
  • 3
    Wattchow DA, Porter AJ, Brookes SJ, Costa M. The polarity of neurochemically defined myenteric neurons in the human colon. Gastroenterology 1997; 113: 497506.
  • 4
    Porter AJ, Wattchow DA, Brookes SJ, Costa M. Cholinergic and nitrergic interneurones in the myenteric plexus of the human colon. Gut 2002; 51: 705.
  • 5
    Coulie B, Camilleri M: Intestinal pseudo-obstruction. Ann Rev Med 1999; 50: 3755.
  • 6
    Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999; 116: 9807.
  • 7
    Kapur RP. Hirschsprung disease and other enteric dysganglionoses. Crit Rev Clin Lab Sci 1999; 36: 22573.
  • 8
    Camilleri M. Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Motil 2001; 13: 27795.
  • 9
    Robertson K, Mason I, Hall I. Hirschsprung's disease: genetic mutations in mice and men. Gut 1997; 41: 43641.
  • 10
    Martucciello G, Ceccherini I, Lerone M, Jasonni V. Pathogenesis of Hirschsprung's disease. J Pediatr Surg 2000; 35: 101725.
  • 11
    Nagaya M, Kato J, Niimi N, Tanaka S, Wakamatsu N. Clinical features of a form of Hirschsprung's disease caused by a novel genetic abnormality. J Pediatr Surg 2002; 37: 111722.
  • 12
    Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol 1999; 17: 38093.
  • 13
    Romeo G, Ceccherini I, Celli J et al. Association of multiple endocrine neoplasia type 2 and Hirschsprung disease. J Int Med 1998; 243: 51520.
  • 14
    Hofstra RMW, Wu Y, Stulp RP et al. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat 2000; 15: 41829.
  • 15
    Doray B, Salomon R, Amiel J et al. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet 1998; 7: 144952.
  • 16
    Pingault V, Bondurand N, Kuhlbrodt K et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Gen 1998; 18: 1713.
  • 17
    Amiel J, Espinosa-Parrilla Y, Steffann J et al. Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet 2001; 69: 13707.
  • 18
    Qualman SJ, Pysher T, Schauer G. Hirschprung disease: differential diagnosis and sequelae. Perspect Pediatr Pathol 1997; 20: 11126.
  • 19
    Weinberg AG. Hirschsprung's disease – a pathologist's view. Perspect Pediatr Pathol 1975; 2: 20739.
  • 20
    Ballard ET. Ultrashort segment Hirschsprung's disease: a case report. Pediatr Pathol Lab Med 1996; 16: 31925.
  • 21
    Nijhawan D, Honarpour N, Wang X. Apoptosis in neural development and disease. Ann Rev Neurosci 2000; 23: 7387.
  • 22
    Palo J, Haltia M, Carpenter S, Karpati G, Mushynski W. Neurofilament subunit-related proteins in neuronal intranuclear inclusions. Ann Neurol 1984; 15: 3228.
  • 23
    Patel H, Norman MG, Perry TL, Berry KE. Multiple system atrophy with neuronal intranuclear hyaline inclusions. Report of a case and review of the literature. J Neurol Sci 1985; 67: 5765.
  • 24
    Munoz-Garcia D, Ludwin SK. Adult-onset neuronal intranuclear hyaline inclusion disease. Neurology 1986; 36: 78590.
  • 25
    Bird TD, Sumi SM, Schuffler MD. Neuronal intranuclear inclusion disease in two adult siblings. Ann Neurol 1985; 17: 2123.
  • 26
    Krishnamurthy S, Schuffler MD. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 1987; 93: 61039.
  • 27
    Krishnamurthy S, Heng Y, Schuffler MD. Chronic intestinal pseudo-obstruction in infants and children caused by diverse abnormalities of the myenteric plexus. Gastroenterology 1993; 104: 1398408.
  • 28
    Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Ann Rev Neurosci 1995; 18: 22353.
  • 29
    Coulie B, Szarka LA, Camilleri M et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology 2000; 119: 4150.
  • 30
    Meier-Ruge WA, Brönnimann PB, Gambazzi F, Schmid PC, Schmidt CP, Stoss F. Histopathological criteria for intestinal neuronal dysplasia of the submucosal plexus. Virch Arch Pathol Anat 1995; 426: 54956.
  • 31
    Cord-Udy CL, Smith VV, Ahmed S, Risdon RA, Milla PJ. An evaluation of the role of suction rectal biopsy in the diagnosis of intestinal neuronal dysplasia. J Pediatr Gastroenterol Nutr 1997; 24: 16.
  • 32
    Achem SR, Owyang C, Schuffler MD, Dobbins WO III. Neuronal dysplasia and chronic intestinal pseudoobstruction: rectal biopsy as a possible aid to diagnosis. Gastroenterology 1987; 92: 8059.
  • 33
    Voderholzer WA, Wiebecke B, Gerum M, Muller-Lissner SA. Dysplasia of the submucous nerve plexus in slow-transit constipation of adults. Eur J Gastroenterol Hepatol 2000; 12: 7559.
  • 34
    Hutson JM, McNamara J, Gibb S, Shin YM. Slow transit constipation in children. J Paediatr Child Health 2001; 37: 42630.
  • 35
    Shekitka KM, Sobin LH. Ganglioneuromas of the gastrointestinal tract. Relation to von Recklinghausen disease and other multiple tumor syndromes. Am J Surg Pathol 1994; 18: 2507.
  • 36
    Carlson KM, Dou S, Chi D et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B genesis. Proc Natl Acad Sci USA 1994; 91: 157983.
  • 37
    Eng C, Clayton D, Schuffenecker I et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis. JAMA 1996; 276: 15759.
  • 38
    Gimm O, Marsh DJ, Andrew SD et al. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 1997; 82: 39024.
  • 39
    Songyang Z, Carraway KL III, Eck MJ et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 1995; 373: 5369.
  • 40
    Santoro M, Carlomagno F, Romano A et al. Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 1995; 267: 3813.
  • 41
    Bongarzone I, Vigano E, Alberti L et al. Full activation of MEN 2B mutant RET by additional MEN 2A mutation or by ligand GDNF stimulation. Oncogene 1998; 16: 2295301.
  • 42
    Gorlin RJ, Sedano HO, Vickers RA, Cervenka J. Multiple mucosal neuromas, phaeochromocytoma and medullary carcinoma of the thyroid-syndrome. Cancer 1968; 22: 2939.
  • 43
    Carney JA, Go VL, Sizemore GW, Hayles AB. Alimentary tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b. N Engl J Med 1976; 295: 128791.
  • 44
    Eng C, Ponder BAJ. Multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. In: GrossmanA, ed. Clinical Endocrinology. Oxford: Blackwell Science, 1998: 63552.
  • 45
    Smith VV, Eng C, Milla PJ. Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment. Gut 1999; 45: 1436.
  • 46
    Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 68992.
  • 47
    Mueller LA, Camilleri M, Emslie-Smith AM. Mitochondrial neuro-gastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology 1999; 116: 95963.
  • 48
    Perez-Atayde AR, Fox V, Teitelbaum JE et al. Mitochondrial neurogastrointestinal encephalo-myopathy: diagnosis by rectal biopsy. Am J Surg Path 1998; 22: 11417.
  • 49
    Hall KE, Wiley JW. Neuronal injury, repair, and adaptation in the GI tract I. New insights into neuronal injury: a cautionary tale. Am J Physiol 1998; 37: G97883.
  • 50
    Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 3346.
  • 51
    Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 13226.
  • 52
    De Giorgio R, Barbara G, Stanghellini V et al. Reduced Bcl-2 expression in the enteric nervous system as a marker for neuronal degeneration in patients with gastrointestinal motor disorders. Gastroenterology 2000; 118: A867 (Abstract).
  • 53
    Kirchgessner AL, Liu MT, Alcantara F. Excitotoxicity in the enteric nervous system. JNeurosci 1997; 17: 880416.
  • 54
    Moudy AM, Handran SD, Goldberg MP et al. Abnormal calcium homeostasis and mitochondrial depolarization in a human encephalomyopathy. Proc Natl Acad Sci USA 1995; 92: 72933.
  • 55
    Krishnamurthy S, Schuffler MD, Belic L, Schweid AI. An inflammatory axonopathy of the myenteric plexus producing a rapidly progressive intestinal pseudoobstruction. Gastroenterology 1986; 90: 7548.
  • 56
    De Giorgio R, Stanghellini V, Barbara G et al. Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol 2000; 35: 11422.
  • 57
    Wood JD. Neuropathy in the brain-in-the-gut. Eur J Gastroenterol Hepatol 2000; 12: 597600.
  • 58
    Rohrmann CA Jr, Ricci MT, Krishnamurthy S, Schuffler MD. Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract: visceral myopathies, visceral neuropathies, and progressive systemic sclerosis. Am J Roentgenol 1984; 143: 93341.
  • 59
    McDonald GB, Schuffler MD, Kadin ME, Tytgat GN. Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine. Gastroenterology 1985; 89: 8829.
  • 60
    Smith VV, Gregson N, Foggensteiner L, Neale G, Milla PJ. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997; 112: 136671.
  • 61
    De Giorgio R, Barbara G, Stanghellini V et al. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol 2000; 12: 6136.
  • 62
    De Giorgio R, Barbara G, Stanghellini V et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002; 97: 24549.
  • 63
    Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000; 24: 11538.
  • 64
    Bogers J, Moreels T, De Man J et al. Schistosoma mansoni infection causing diffuse enteric inflammation and damage of the enteric nervous system in the mouse small intestine. Neurogastroenterol Motil 2000; 12: 43140.
  • 65
    Schappi MG, Smith VV, Milla PJ, Lindley KJ. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003; 52: 7525.
  • 66
    Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001; 96: 3739.
  • 67
    Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 1999; 53: 12339.
  • 68
    Pande R, Leis AA. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 1999; 22: 16002.
  • 69
    Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002; 20: 85122.
  • 70
    Eaker EY, Kuldau JG, Verne GN, Ross SO, Sallustio JE. Myenteric neuronal antibodies in scleroderma: passive transfer evokes alterations in intestinal myoelectric activity in a rat model. J Lab Clin Med 1999; 133: 5516.
  • 71
    Lennon VA. Calcium channel and related paraneoplastic disease autoantibodies. In: PeterJB, ShoenfeldY, eds. Textbook of Autoantibodies. Amsterdam, The Netherlands: Elsevier Science, 1996: 13947.
  • 72
    Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999; 45: 1627.
  • 73
    Wakamatsu Y, Weston JA. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 1997; 124: 344960.
  • 74
    De Giorgio R, Bovara M, Barbara G et al. Anti-HuD- induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 2003; 125: 709.
  • 75
    Waterman SA. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res 2001; 11: 14554.
  • 76
    Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000; 343: 84755.
  • 77
    Okano HJ, Park WY, Corradi JP, Darnell RB. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev 1999; 13: 208797.
  • 78
    Moses PL, Ellis LM, Anees MR et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003; 52: 62936.
  • 79
    Schuffler MD, Baird HW, Fleming CR et al. Intestinal pseudoobstruction as the presenting manifestation of small-cell carcinoma of the lung. Ann Intern Med 1983; 98: 12934.
  • 80
    Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988; 95: 127986.
  • 81
    Schobinger-Clement S, Gerber HA, Stallmach T. Autoaggressive inflammation of the myenteric plexus resulting in intestinal pseudoobstruction. Am J Surg Pathol 1999; 23: 6026.
  • 82
    Meneghelli UG. Chagas’ disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res 1985; 18: 25564.
  • 83
    Andersson J, Orn A, Sunnemark D. Chronic murine Chagas’ disease: the impact of host and parasite genotypes. Immunol Lett 2003; 86: 20712.
  • 84
    Caliari ER, Caliari MV, de Lana M, Tafuri WL. Quantitative and qualitative studies of the Auerbach and Meissner plexuses of the esophagus in dogs inoculated with Trypanosoma cruzi. Rev Soc Bras Med Trop 1996; 29: 1720.
  • 85
    Horoupian DS, Kim Y. Encephalomyeloneuropathy with ganglionitis of the myenteric plexuses in the absence of cancer. Ann Neurol 1982; 11: 62832.
  • 86
    DeSchryver-Kecskemeti K, Clouse RE. Perineural and intraneural inflammatory infiltrates in the intestines of patients with systemic connective-tissue disease. Arch Pathol Lab Med 1989; 113: 3948.
  • 87
    Geboes K, Collins S. Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol Motil 1998; 10: 189202.
  • 88
    Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 19729.
  • 89
    Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996; 111: 64854.
  • 90
    Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 177883.
  • 91
    Saur D, Seidler B, Paehge H, Schusdziarra V, Allescher HD. Complex regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors. J Biol Chem 2002; 277: 25798814.
  • 92
    Krishnamurthy S, Schuffler MD, Rohrmann CA, Pope CE II. Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 1985; 88: 2634.
  • 93
    Koch TR, Carney JA, Go L, Go VL. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology 1988; 94: 30010.
  • 94
    Schouten WR, Ten Kate FJ, de Graaf EJ, Gilberts EC, Simons JL, Kluck P. Visceral neuropathy in slow transit constipation: an immunohistochemical investigation with monoclonal antibodies against neurofilament. Dis Colon Rectum 1993; 36: 11127.
  • 95
    Park HJ, Kamm MA, Abbasi AM, Talbot IC. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum 1995; 38: 50913.
  • 96
    Cortesini C, Cianchi F, Infantino A, Lise M. Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci 1995; 40: 24505.
  • 97
    Hutson JM, Chow CW, Hurley MR, Uemura S, Wheatley JM, Catto-Smith AG. Deficiency of substance P-immunoreactive nerve fibres in children with intractable constipation: a form of intestinal neuronal dysplasia. J Paediatr Child Health 1997; 33: 1879.
  • 98
    Tzavella K, Riepl RL, Klauser AG, Vodeholzer WA, Schindlbeck NE, Muller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 1996; 8: 120711.
  • 99
    Sjolund K, Fasth S, Ekman R et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil 1997; 9: 14350.
  • 100
    Porter AJ, Wattchow DA, Hunter A, Costa M. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int J Colorectal Dis 1998; 13: 20816.
  • 101
    Faussone-Pellegrini MS, Infantino A, Matini P, Masin A, Mayer B, Lise M. Neuronal anomalies and normal muscle morphology at the hypomotile ileocecocolonic region of patients affected by idiopathic chronic constipation. Histol Histopathol 1999; 14: 111934.
  • 102
    El-Salhy M, Norrgard O, Spinnell S. Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol 1999; 34: 100711.
  • 103
    He CL, Burgart L, Wang L et al. Decreased interstitial cell of Cajal volume in patients with slow-transit constipation. Gastroenterology 2000; 118: 1421.
  • 104
    Lyford GL, He C-L, Soffer E et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow-transit constipation. Gut 2002; 51: 496501.
  • 105
    Wedel T, Spiegler J, Soellner S et al. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 2002; 123: 145967.
  • 106
    Sabri M, Barksdale E, Di Lorenzo C. Constipation and lack of interstitial cells of Cajal. Dig Dis Sci 2003; 48: 84953.
  • 107
    Hagger R, Finlayson C, Kahn F, De Oliveira R, Chimelli L, Kumar D. A deficiency of interstitial cells of Cajal in Chagasic megacolon. J Auton Nerv Syst 2000; 80: 10811.
  • 108
    Faussone-Pellegrini MS, Fociani P, Buffa R, Basilisco G. Loss of interstitial cells of Cajal and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient. Gut 1999; 45: 7759.
  • 109
    Lembo T, Camilleri M. Chronic constipation. N Engl J Med 2003; 349: 13608.
  • 110
    Singaram C, Ashraf W, Gaumnitz EA et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 1995; 346: 8614.
  • 111
    Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF. Defecatory function in Parkinson's disease: response to apomorphine. Ann Neurol 1993; 33: 4903.
  • 112
    Thuneberg L. Interstitial cells of Cajal: intestinal pacemaker cells? Adv Anat Embryol Cell Biol 1982; 71: 1130.
  • 113
    Cajal SR. Sur les ganglions et plex nerveux de l'intestin. CR Soc Biol (Paris) 1893; 45: 21723.
  • 114
    Lee JC, Thuneberg L, Berezin I, Huizinga JD. Generation of slow waves in membrane potential is an intrinsic property of interstitial cells of Cajal. Am J Physiol 1999; 277: G40923.
  • 115
    Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996; 111; 492515.
  • 116
    Ward SM, Sanders KM. Physiology and pathophysiology of the interstitial cell of Cajal: from bench to bedside. I. Functional development and plasticity of interstitial cells of Cajal networks. Am J Physiol 2001; 281: G60211.
  • 117
    Vannucchi MG. Receptors in interstitial cells of Cajal: identification and possible physiological roles. Microsc Res Tech 1999; 47: 32535.
  • 118
    Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 1995; 373: 3479.
  • 119
    Huizinga JD, Thuneberg L, Vanderwinden JM, Rumessen JJ. Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders. Trends Pharmacol Sci 1997; 18: 393403.
  • 120
    Sanders KM, Ördög T, Ward SM. Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal. Am J Physiol 2002; 282: G74756.
  • 121
    Streutker CJ, Huizinga JD, Campbell F, Ho J, Riddell RH. Loss of CD117 (c-kit)- and CD34-positive ICC and associated CD34-positive fibroblasts defines a subpopulation of chronic intestinal pseudo-obstruction. Am J Surg Pathol 2003; 27: 22835.
  • 122
    Faussone-Pellegrini MS, Cortesini C. The muscle coat of the lower esophageal sphincter in patients with achalasia and hypertensive sphincter. An electron microscopic study. J Submicrosc Cytol 1985; 17: 67385.
  • 123
    Khelif K, De Laet MH, Chaouachi B, Segers V, Vanderwinden JM. Achalasia of the cardia in Allgrove's (triple A) syndrome: histopathologic study of 10 cases. Am J Surg Pathol 2003; 27: 66772.
  • 124
    Vanderwinden JM, Liu H, De Laet MH, Vanderhaeghen JJ. Study of the interstitial cells of Cajal in infantile hypertrophic pyloric stenosis. Gastroenterology 1996; 111: 27988.
  • 125
    Zarate N, Mearin F, Wang XY, Hewlett B, Huizinga JD, Malagelada JR. Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management. Gut 2003; 52: 96670.
  • 126
    Vanderwinden JM, Rumessen JJ, Liu H, Descamps D, De Laet MH, Vanderhaeghen JJ. Interstitial cells of Cajal in human colon and in Hirschsprung's disease. Gastroenterology 1996; 111: 90110.
  • 127
    Isozaki K, Hirota S, Miyagawa J-I, Taniguchi M, Shinomura Y, Matsuzawa Y. Deficiency of c-kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction. Am J Gastroenterol 1997; 92: 3324.
  • 128
    Boeckxstaens GE, Rumessen JJ, de Wit L, Tytgat GNJ, Vanderwinden JM. Abnormal distribution of the interstitial cells of Cajal in an adult patient with pseudo-obstruction and megaduodenum. Am J Gastroenterol 2002; 97: 21206.
  • 129
    Jain D, Moussa K, Tandon M, Culpepper-Morgan J, Proctor DD. Role of interstitial cells of Cajal in motility disorders of the bowel. Am J Gastroenterol 2003; 98: 61824.
  • 130
    Feldstein AE, Miller SM, El-Youssef M et al. Chronic intestinal pseudoobstruction associated with altered interstitial cells of Cajal network. J Pediatr Gastroenterol Nutr 2003; 36: 4927.
  • 131
    Kenny SE, Vanderwinden JM, Rintala RJ et al. Delayed maturation of the interstitial cells of Cajal: a new diagnosis for transient neonatal pseudo-obstruction. Report of two cases. J Pediatr Surg 1998; 33: 948.
  • 132
    Ordog T, Takayama I, Cheung WK, Ward SM, Sanders KM. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49: 17319.
  • 133
    He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121: 42734.
  • 134
    Torihashi S, Nishi K, Tokutomi Y, Nishi T, Ward S, Sanders KM. Blockade of kit signaling induces transdifferentiation of interstitial cells of Cajal to a smooth muscle phenotype. Gastroenterology 1999; 117: 1408.
  • 135
    O'Brien MD, Bruce BK, Camilleri M. Rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology 1995; 108: 10249.
  • 136
    Chial HJ, Camilleri M, Williams DE, Litzinger K, Perrault J. Rumination syndrome in children and adolescents: diagnosis, treatment and prognosis. Pediatrics 2003; 111: 15862.
  • 137
    Stanghellini V, Camilleri M, Malagelada J-R. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987; 28: 512.
  • 138
    Hyman PE, Mc Diramid SV, Napolitano JA, Abrams CE, Tomomasa T. Antroduodenal motility in children with chronic intestinal pseudo-obstruction. J Pediatr 1988; 112: 899905.
  • 139
    Camilleri M, Hasler WL, Parkman HP, Quigley EMM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115: 74762.
  • 140
    Di Lorenzo C, Flores AF, Reddy SN, Snape WJ Jr, Bazzocchi G, Hyman PE. Colonic manometry in children with chronic intestinal pseudo-obstruction. Gut 1993; 34: 8037.
  • 141
    O'Brien MD, Camilleri M, von der Ohe MR et al. Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol 1996; 91: 25328.